Vertaling van "approval in january " (Nederlands → Frans) :

In Japan, three medicines – Afinitor (kidney cancer), Equa (type 2 diabetes) and Exforge (hypertension) – gained regulatory approvals in January.
En janvier, trois médicaments – Afinitor (cancer du rein), Equa (diabète de type 2) et Exforge (hypertension) – ont été autorisés au Japon.

Rasilez HCT, a singlepill combination with a diuretic, received EU approval in January 2009, while a decision in Switzerland is expected in 2009.
Rasilez HCT, un comprimé associant un diurétique, a été homologué par l’Union européenne en janvier 2009, tandis qu’une décision de l’autorité réglementaire suisse est attendue en 2009.

Rasilez HCT, a single-pill combination with a diuretic, has been launched in Europe after approval in January 2009.
Rasilez HCT, un comprimé l’associant à un diurétique, est maintenant commercialisé en Europe après l’autorisation délivrée en janvier 2009.

Approvals in Japan in January for Afinitor (kidney cancer), Equa (Galvus) (type 2 diabetes) and Exforge (hypertension) following approvals of six new medicines in this market in 2009.
Les autorisations délivrées en janvier au Japon pour Afinitor (cancer du rein), Equa (Galvus) (diabète de type 2) et Exforge (hypertension), qui font suite aux six homologations de nouveaux médicaments obtenues dans ce marché en 2009.

Exforge received regulatory approval in Japan in January 2010, while Exforge HCT, which adds a diuretic in a single pill, has been a key growth driver in both the US and Europe.
Exforge a reçu en janvier 2010 une autorisation de mise sur le marché au Japon, tandis qu’Exforge HCT, qui y ajoute un diurétique en un seul comprimé, a été un moteur-clé de la croissance tant aux Etats-Unis qu’en Europe.

Galvus was approved in Japan in January 2010 under the brand name Equa.
Galvus a été homologué en janvier 2010 au Japon sous la marque Equa.

narcotics and concerning risk limitation and therapeutic advice and of 22 January 1998 governing certain psychotropic substances and concerning risk limitation and therapeutic advice and of 12 April 1974 containing certain provisions relating to substances with hormonal, antihormonal, anabolic, beta-adrenergic, anti-infectious, antiparasitic and anti-inflammatory action Law of 15 July 1985 on the use in animals of substances with hormonal, anti-hormonal, beta-adrenergic or production stimulating action Law of 13 June 1986 on the removal and transplanting of organs, with regard to cells and tissues Law of 28 August 1991 on the practice of veterinary medicine, regarding the provision of medicines to animal carers Law of 5 July 1994 on blood and blood derivatives of human origin Law of 7 May 2004 on experiments on the human person Royal decree of 31 May 1885 approving new instructions for physicians, pharmacists and druggists Royal decree of 22 September 1966 on the conditions and arrangements for the recognition of laboratories for the analysis and checking of medicines Royal decree of 6 June 1960 on the production, preparation and wholesale distribution and delivery of medicines Royal decree no. 78 of 10 November 1967 on the practice of the healthcare professions regarding the dispensing of medicines to the public and Royal decree of 25 September
narcotics and concerning risk limitation and therapeutic advice and of 22 January 1998 governing certain psychotropic substances and concerning risk limitation and therapeutic advice and of 12 April 1974 containing certain provisions relating to substances with hormonal, antihormonal, anabolic, beta-adrenergic, anti-infectious, antiparasitic and anti-inflammatory action Law of 15 July 1985 on the use in animals of substances with hormonal, anti-hormonal, beta-adrenergic or production stimulating action Law of 13 June 1986 on the removal and transplanting of organs, with regard to cells and tissues Law of 28 August 1991 on the practice of veterinary medicine, regarding the provision of medicines to animal carers Law of 5 July 1994 on blood and blood derivatives of human origin Law of 7 May 2004 on experiments on the human person Royal decree of 31 May 1885 approving new instructions for physicians, pharmacists and druggists Royal decree of 22 September 1966 on the conditions and arrangements for the recognition of laboratories for the analysis and checking of medicines Royal decree of 6 June 1960 on the production, preparation and wholesale distribution and delivery of medicines Royal decree no. 78 of 10 November 1967 on the practice of the healthcare professions regarding the dispensing of medicines to the public and Royal decree of 25 September

Since 1 January 2007, the law has been in force requiring a preliminary approval for the payment by pharmaceutical companies or producers of medical devices of the participation costs of healthcare professionals in scientific events involving at least one night’s accommodation.
Since 1 January 2007, the law has been in force requiring a preliminary approval for the payment by pharmaceutical companies or producers of medical devices of the participation costs of healthcare professionals in scientific events involving at least one night’s accommodation.

Exforge received approval in Japan in January 2010.
Exforge a été homologué au Japon en janvier 2010.